|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.55 USD | -2.82% |
|
-2.06% | -14.81% |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -4.1x | - | -105.05x | - | - | -0.36x | - | 272M | |
| 38.88x | 4.01x | 0.63x | 5.65x | 18.93x | 27.72x | 0.88% | 48.93B | |
| 33.47x | 6.37x | -6.45x | 3.33x | 14.23x | 23.08x | -.--% | 40.48B | |
| 103.47x | 9.36x | -0.67x | 6.63x | 66.61x | 96.73x | -.--% | 37.42B | |
| 55.18x | 2.64x | 0.6x | 11.32x | 31.46x | 40.61x | 0.35% | 31.03B | |
| -21.53x | 14.65x | -0.38x | 6248.57x | -20.41x | -20.17x | -.--% | 23.25B | |
| 41.27x | 41.21x | 2.4x | 6.69x | 30.41x | 31.88x | -.--% | 17.21B | |
| 27.71x | 2.47x | 0.66x | 2.23x | 10x | 15.46x | 0.88% | 14.78B | |
| 27.1x | 1.49x | -0.93x | 2.1x | 10.74x | 11.95x | -.--% | 13.94B | |
| -51.76x | 1364.97x | 1.09x | 15.02x | -109.93x | -83.63x | -.--% | 12.63B | |
| -47.32x | 24.46x | 0.62x | 10.37x | 37001.27x | -214.62x | -.--% | 12.51B | |
| -33.68x | 44.9x | 1.32x | 12.73x | -36.3x | -31.82x | -.--% | 12.36B | |
| 52.39x | 3.07x | 0.03x | 3.18x | 13.19x | 16.05x | -.--% | 10.81B | |
| 53.65x | 4.92x | 0.3x | 8.71x | 24.66x | 26.85x | 0.47% | 10.7B | |
| 23.88x | 2.58x | 0.06x | 4.85x | 13.12x | 16.37x | 0.28% | 9.8B | |
| Average | 19.91x | 109.08x | -7.05x | 452.95x | 2,647.71x | -2.93x | 0.2% | 19.74B | |
| Weighted average by Cap. | 32.25x | 68.31x | -0.66x | 497.30x | 1,578.35x | 13.95x | 0.25% |
- Stock Market
- Equities
- NGNE Stock
- Sector Neurogene Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition